Tag Archives: Bridge Medicines

Bridge Medicines appoints William J. Polvino as Chief Executive Officer

Bridge Medicines appoints William J. Polvino as Chief Executive OfficerAs Chief Executive Officer of the newly formed drug discovery company, founded by Rockefeller University and its two neighboring institutions, Polvino will be responsible for building a portfolio of early-stage drug discovery projects and advancing each program from animal proof of principle to clinical trials. More »

Tags: , , ,

Pioneering drug discovery company Bridge Medicines launched to advance promising early technologies in major academic institutions through human proof of concept

Pioneering drug discovery company bridge medicines launched to advance promising early technologies in major academic institutions through human proof of conceptThe Tri-Institutional Therapeutics Discovery Institute, a partnership between Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine and Takeda, joins with Deerfield Management and Bay City Capital to create an accelerated path to innovative therapies to treat disease.
More »

Tags: , , ,